2009-2011 국민건강영양조사를 이용한 비타민 D와 골근감소증 사이의 관련성
25-Hydroxyvitamin D is Associated with Osteosarcopenia: the 2009-2011 Korea National Health and Nutrition Examination Survey
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: This study was conducted to identify the association among vitamin D and osteoporosis, sarcopenia, osteosarcopenia in adults ≥ 50 years old using the 2009-2011 Korea National Health and Nutrition Survey. Methods: This study involved 6,635 (2,908 males and 3,727 females) participants in the 2009-2011 KNHANES aged 50 years or older. Bone mineral density and appendicular skeletal muscle mass (ASM) was measured by dual X-ray absorptiometry. Sarcopenia was defined as an ASM divided by body mass index (BMI) (ASM [kg]÷BMI [kg/m2 ]) value of < 0.789 in males and < 0.512 in females and osteoporosis was defined as T-score < -2.5 at lumbar or femur neck. Osteosarcopenia was defined as having osteoporosis and sarcopenia. Results: After adjusting for covariates and parathyroid hormone, the level of vitamin D was negatively associated with osteoporosis at femur neck (odds ratio [OR] 1.68, 95 % confidence interval [CI] 1.02–2.77 for < 10.0 vs. ≥ 30.0, OR 1.45, 95 % CI 1.02-2.06 for 10.0-19.9 vs. ≥ 30.0) sarcopenia (OR 1.92, 95 % CI 1.11-3.34 for < 10.0 vs. ≥ 30.0) and osteosarcopenia (OR 2.28, 95 % CI 1.06-4.90 for < 10.0 vs. ≥ 30.0). Conclusions: There were significant associations of vitamin D with osteoporosis, sarcopenia and osteosarcopenia independent of PTH in Korean adults 50 years old and over.
Abstract
Objectives: This study was conducted to identify the association among vitamin D and osteoporosis, sarcopenia, osteosarcopenia in adults ≥ 50 years old using the 2009-2011 Korea National Health and Nutrition Survey. Methods: This study involved 6,635 (2,908 males and 3,727 females) participants in the 2009-2011 KNHANES aged 50 years or older. Bone mineral density and appendicular skeletal muscle mass (ASM) was measured by dual X-ray absorptiometry. Sarcopenia was defined as an ASM divided by body mass index (BMI) (ASM [kg]÷BMI [kg/m2 ]) value of < 0.789 in males and < 0.512 in females and osteoporosis was defined as T-score < -2.5 at lumbar or femur neck. Osteosarcopenia was defined as having osteoporosis and sarcopenia. Results: After adjusting for covariates and parathyroid hormone, the level of vitamin D was negatively associated with osteoporosis at femur neck (odds ratio [OR] 1.68, 95 % confidence interval [CI] 1.02–2.77 for < 10.0 vs. ≥ 30.0, OR 1.45, 95 % CI 1.02-2.06 for 10.0-19.9 vs. ≥ 30.0) sarcopenia (OR 1.92, 95 % CI 1.11-3.34 for < 10.0 vs. ≥ 30.0) and osteosarcopenia (OR 2.28, 95 % CI 1.06-4.90 for < 10.0 vs. ≥ 30.0). Conclusions: There were significant associations of vitamin D with osteoporosis, sarcopenia and osteosarcopenia independent of PTH in Korean adults 50 years old and over.
참고문헌 (39)
- World Health Organization, "Prevention and management of osteoporosis" (2003), World Health Organization
- Looker AC, "Prevalence and trends in low femur bone density among older US adults : NHANES 2005-2006 compared with NHANES III", J Bone Miner Res, 25(1), pp.64~71 (2010)[DOI]
- 이관, "골다공증 관리와 과학적 근거", 대한의사협회지, 54(3), pp.294~302 (2011), 대한의사협회
- Rosenberg IH, "Sarcopenia : origins and clinical relevance", J Nutr, 127(5 Suppl), pp.990S~991S (1997)[DOI]
- Janssen I, "Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability", J Am Geriatr Soc, 50(5), pp.889~896 (2002)[DOI]
- 홍상모, "Sarcopenia의 최신지견: 근감소증", 대한내과학회지, 83(4), pp.444~454 (2012), 대한내과학회[DOI]
- Visser M, "Consequences of sarcopenia", Clin Geriatr Med, 27(3), pp.387~399 (2011)[DOI]
- Roubenoff R, "Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study", Am J Med, 115(6), pp.429~435 (2003)[DOI]
- Reginster JY, "Osteoporosis and sarcopenia : two diseases or one?", Curr Opin Clin Nutr Metab Care, 19(1), pp.31~36 (2016)[DOI]
- Binkley N, "Beyond FRAX : it’s time to consider"sarcoosteopenia"", J Clin Densitom, 12(4), pp.413~416 (2009)[DOI]
- Wang YJ, "Sarco-Osteoporosis : prevalence and association with frailty in Chinese communitydwelling older adults", Int J Endocrinol, 2015, pp.482940~ (2015)[DOI]
- Huo YR, "Phenotype of osteosarcopenia in older individuals with a history of falling", J Am Med Dir Assoc, 16(4), pp.290~295 (2015)[DOI]
- Kasper DL, "Harrison’s principles of internal Medicine" (2004), McGraw-Hill Professional
- Holick MF, "Cancer, sunlight and vitamin D", J Clin Transl Endocrinol, 1(4), pp.179~186 (2014)[DOI]
- Gandini S, "Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma", Int J Cancer, 128(6), pp.1414~1424 (2011)[DOI]
- Naghshtabrizi B, "Evaluation of the relationship between serum 25-hydroxy vitamin D and hypertension in Hamadan, Iran-A Case Control Study", J Clin Diagn Res, 11(7), pp.LC01~LC03 (2017)[DOI]
- Lips P, "Vitamin D and type 2 diabetes", J Steroid Biochem Mol Biol, 173, pp.280~285 (2017)[DOI]
- Leu Agelii M, "Low vitamin D status in relation to cardiovascular disease and mortality in Swedish women-Effect of extended follow-up", Nutr Metab Cardiovasc Dis, 27(12), pp.1143~1151 (2017)[DOI]
- Lips P, "A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis : baseline data from the multiple outcomes of raloxifene evaluation clinical trial", J Clin Endocrinol Metab, 86(3), pp.1212~1221 (2001)[DOI]
- Baumgartner RN, "Epidemiology of sarcopenia among the elderly in New Mexico", Am J Epidemiol, 147(8), pp.755~763 (1998)[DOI]
- Sahota O, "The relationship between vitamin D and parathyroid hormone : calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis", Bone, 35(1), pp.312~319 (2004)[DOI]
- Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)", Int J Epidemiol, 43(1), pp.69~77 (2014)[DOI]
- Studenski SA, "The FNIH sarcopenia project : rationale, study description, conference recommendations, and final estimates", J Gerontol A Biol Sci Med Sci, 69(5), pp.547~558 (2014)[DOI]
- Thacher TD, "Vitamin D insufficiency", Mayo Clin Proc, 86(1), pp.50~60 (2011)[DOI]
- Huo YR, "Comprehensive nutritional status in sarco-osteoporotic older fallers", J Nutr Health Aging, 19(4), pp.474~480 (2015)[DOI]
- Chen LK, "Sarcopenia in Asia : consensus report of the Asian Working Group for Sarcopenia", J Am Med Dir Assoc, 15(2), pp.95~101 (2014)[DOI]
- Cruz-Jentoft AJ, "Sarcopenia : European consensus on definition and diagnosis : Report of the European Working Group on Sarcopenia in Older People", Age Ageing, 39(4), pp.412~423 (2010)[DOI]
- Bischoff-Ferrari HA, "Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis", Arthritis Rheum, 53(6), pp.821~826 (2005)[DOI]
- Choi SW, "The association between vitamin D and parathyroid hormone and bone mineral density : the Dong-gu Study", J Bone Miner Metab, 34(5), pp.555~563 (2016)[DOI]
- Marantes I, "Is vitamin D a determinant of muscle mass and strength", J Bone Miner Res, 26(12), pp.2860~2871 (2011)[DOI]
- Kim MK, "Vitamin D deficiency is associated with sarcopenia in older Koreans, re-gardless of obesity: the fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009", J Clin Endocrinol Metab, 96(10), pp.3250~3256 (2011)[DOI]
- Baczynski R, "Effect of parathyroid hormone on energy metabolism of skeletal muscle", Kidney Int, 28(5), pp.722~727 (1985)[DOI]
- Visser M, "Relationship of interleukin-6 and tumor necrosis factoralpha with muscle mass and muscle strength in elderly men and women : the Health ABC Study", J Gerontol A Biol Sci Med Sci, 57(5), pp.M326~M332 (2002)[DOI]
- Boland R, "Role of vitamin D in skeletal muscle function", Endocr Rev, 7(4), pp.434~448 (1986)[DOI]
- Visser M, "Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam", J Clin Endocrinol Metab, 88(12), pp.5766~5772 (2003)[DOI]
- Roth SM, "Inflammatory factors in agerelated muscle wasting", Curr Opin Rheumatol, 18(6), pp.625~630 (2006)[DOI]
- Schleithoff SS, "Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial", Am J Clin Nutr, 83(4), pp.754~759 (2006)[DOI]
- Kim J, "Association of serum vitamin D with osteosarcopenic obesity : Korea National Health and Nutrition Examination Survey 2008-2010", J Cachexia Sarcopenia Muscle, 8(2), pp.259~266 (2017)[DOI]
- Suriyaarachchi P, "High parathyroid hormone levels are associated with osteosarcopenia in older individuals with a history of falling", Maturitas, 113, pp.21~25 (2018)[DOI]
